Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

Abstract

Objectives To determine the expression of prostate-specific membrane antigen (PSMA) before and after androgen-deprivation therapy and to compare PSMA expression with prostate-specific antigen (PSA) expression. Methods We studied specimens from 20 patients with prostate cancer undergoing medical or surgical castration or combination androgen-deprivation therapy in whom matched pretreatment and post-treatment tissue specimens were available and 16 patients in whom only a post-treatment specimen was available. The expression of PSMA and PSA in the tissue specimens was determined by immunoperoxidase staining. The extent of staining was calculated by multiplying the percent of antigen-positive tumor cells by the staining intensity to arrive at a stain index for each biomarker. An in vitro study assessed the concentration of PSMA and PSA in extracts of LNCaP cells cultured in the presence or absence of androgen as determined by immunoassays and Western blot analysis. Results PSMA reactivity was found to be increased in 55% (11 of 20) of post-treatment primary tissues and 100% (4 of 4) of post-treatment metastatic specimens. In contrast, PSA expression was found to be decreased in 70% (14 of 20) of post-treatment primary and 100% (4 of 4) of post-treatment metastatic specimens. Neither type of androgen-deprivation treatment nor tissue sensitivity to androgen deprivation appeared to influence degree of biomarker expression. PSMA was found to be downregulated and PSA upregulated when…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0090-4295(96)00184-7

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. Horoszewicz, 1987, Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients, Anticancer Res, 7, 927
  2. Kantoff, 1993, Advances in nonsurgical management of prostate cancer, Adv Oncol, 9, 24

Cited by

See all 639

Metadata

Authors
Wright, G. L., Mayer Grob, B., Haley, C., Grossman, K., Newhall, K., Petrylak, D., Troyer, J., Konchuba, A., Schellhammer, P. F., & Moriarty, R.
Affiliations
Eastern Virginia Medical School (US)
Corresponding author
Wright, George L.
Venue
Urology
Publisher
Elsevier BV
Published
1996-08
Volume
48
Issue
2
Pages
326-334
ISSN
0090-4295 (ISSN-L)
OpenAlex
W2016973566
Cited by
635
References
36
Citations by year
2026: 14 · 2025: 14 · 2024: 20 · 2023: 22 · 2022: 25 · 2021: 38 · 2020: 18 · 2019: 34 · 2018: 37 · 2017: 44 · 2016: 34 · 2015: 30 · 2014: 21 · 2013: 21 · 2012: 24
FWCI
10.90
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Urology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Keywords
prostate-specific membrane antigen, androgen deprivation therapy, prostate cancer, prostate-specific antigen, castration, LNCaP cells, androgen receptor, metastatic prostate cancer, castration-resistant prostate cancer, biomarker expression
MeSH terms
Androgen Antagonists, Antigens, Neoplasm, Antigens, Surface, Dipeptidases, Humans, Male, Orchiectomy, Prostatic Neoplasms, Tumor Cells, Cultured, Up-Regulation, Prostate-Specific Antigen, Glutamate Carboxypeptidase II, Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. https://app.cochat.ai/papers/10.1016/s0090-4295(96)00184-7
The paper
Wright, G. L., Mayer Grob, B., Haley, C., Grossman, K., Newhall, K., Petrylak, D., Troyer, J., Konchuba, A., Schellhammer, P. F., & Moriarty, R. (1996). Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology. https://doi.org/10.1016/s0090-4295(96)00184-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.